Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.040 EUR
98.81 M EUR
894.24 M EUR
572.91 M
About SIMCERE PHARMACEUTICAL GRP LTD
Sector
Industry
CEO
Jin Sheng Ren
Website
Headquarters
Nanjing
Founded
1995
ISIN
HK0000658531
FIGI
BBG00Y04NC95
Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. It operates through the Sale of Pharmaceutical Products and Promotion Service Income segments. The Promotion Service Income segment includes the rendering promotion service of pharmaceutical products that are not manufactured by the firm. The company was founded by Jin Sheng Ren in 1995 and is headquartered in Nanjing, China.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of S2P is 0.975 EUR — it has increased by 0.52% in the past 24 hours. Watch SIMCERE PHARMAC. GRP LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SIMCERE PHARMAC. GRP LTD stocks are traded under the ticker S2P.
S2P stock has risen by 13.37% compared to the previous week, the month change is a 10.17% rise, over the last year SIMCERE PHARMAC. GRP LTD has showed a 61.16% increase.
We've gathered analysts' opinions on SIMCERE PHARMAC. GRP LTD future price: according to them, S2P price has a max estimate of 1.24 EUR and a min estimate of 0.98 EUR. Watch S2P chart and read a more detailed SIMCERE PHARMAC. GRP LTD stock forecast: see what analysts think of SIMCERE PHARMAC. GRP LTD and suggest that you do with its stocks.
S2P stock is 0.51% volatile and has beta coefficient of 0.56. Track SIMCERE PHARMAC. GRP LTD stock price on the chart and check out the list of the most volatile stocks — is SIMCERE PHARMAC. GRP LTD there?
Today SIMCERE PHARMAC. GRP LTD has the market capitalization of 2.46 B, it has decreased by −5.92% over the last week.
Yes, you can track SIMCERE PHARMAC. GRP LTD financials in yearly and quarterly reports right on TradingView.
SIMCERE PHARMAC. GRP LTD is going to release the next earnings report on Aug 21, 2025. Keep track of upcoming events with our Earnings Calendar.
S2P net income for the last half-year is 37.29 M EUR, while the previous report showed 59.14 M EUR of net income which accounts for −36.94% change. Track more SIMCERE PHARMAC. GRP LTD financial stats to get the full picture.
Yes, S2P dividends are paid annually. The last dividend per share was 0.021 EUR. As of today, Dividend Yield (TTM)% is 2.01%. Tracking SIMCERE PHARMAC. GRP LTD dividends might help you take more informed decisions.
SIMCERE PHARMAC. GRP LTD dividend yield was 2.40% in 2024, and payout ratio reached 53.80%. The year before the numbers were 2.61% and 58.03% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 25, 2025, the company has 6.58 K employees. See our rating of the largest employees — is SIMCERE PHARMAC. GRP LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SIMCERE PHARMAC. GRP LTD EBITDA is 164.66 M EUR, and current EBITDA margin is 18.43%. See more stats in SIMCERE PHARMAC. GRP LTD financial statements.
Like other stocks, S2P shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SIMCERE PHARMAC. GRP LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SIMCERE PHARMAC. GRP LTD technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SIMCERE PHARMAC. GRP LTD stock shows the buy signal. See more of SIMCERE PHARMAC. GRP LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.